Smith & Nephew SNATS, Inc. Common Stock (NY:SNN)

27.42 -0.20 (-0.72%)

Streaming Delayed Price Updated: 1:23 PM EDT, Sep 11, 2026 Add to My Watchlist

Price and Volume

Volume	719,693
Open	27.87
Bid (Size)	27.42 (500)
Ask (Size)	27.43 (600)
Prev. Close	27.62
Today's Range	27.23 - 27.91
52wk Range	27.55 - 38.59
Shares Outstanding	N/A
Dividend Yield	3.52%

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Smith & Nephew Plc Announces Cash Tender Offer for 2030 Bonds Up To $250m

September 08, 2026

Smith+Nephew announces cash tender offer for up to $250 million of its outstanding 2.032% notes due 2030

From Smith & Nephew Plc

Via ACCESS Newswire

Smith & Nephew (NYSE:SNN) Looks Undervalued on Decent Value Screen ↗

August 28, 2026

Via Chartmill

Performance

YTD	-16.6%	-16.6%
1 Month	-8.6%	-8.6%
3 Month	-10.6%	-10.6%
6 Month	-17.0%	-17.0%
1 Year	-27.8%	-27.8%

More News

Smith+Nephew and Imperial College London launch centre to accelerate innovation in surgical robotics

August 18, 2026

From Smith & Nephew UK Ltd

Via GlobeNewswire

Smith+Nephew’s new FLOW FLEXTEND™ COBLATION™ Wand improves access¹* and resection efficiency²** for complex hip procedures vs. fixed-angle options

August 17, 2026

From Smith & Nephew UK Ltd

Via GlobeNewswire

Smith & Nephew SNATS Q2 Earnings Call Highlights ↗

August 09, 2026

Via MarketBeat

Smith & Nephew plc (NYSE:SNN) Caviar Cruise Screen Analysis ↗

July 01, 2026

Via Chartmill

Smith & Nephew (NYSE:SNN) Qualifies as a Quality Investment Through the Caviar Cruise Screen ↗

April 24, 2026

Via Chartmill

Smith & Nephew PLC (NYSE:SNN) Passes the Caviar Cruise Screen for Quality Investing ↗

April 02, 2026

Via Chartmill

Smith+Nephew celebrates mobility, recovery and football's greatest traditions during Pro Football Hall of Fame Enshrinement Week

August 05, 2026

From Smith & Nephew UK Ltd

Via GlobeNewswire

Smith & Nephew (SNN) Q2 2026 Earnings Call Transcript ↗

August 04, 2026

Via The Motley Fool

Smith+Nephew’s TESSA™ Spatial Surgery System granted De Novo classification by the FDA sparking a generational leap in Sports Medicine for personalized planning and procedural innovation

July 29, 2026

From Smith & Nephew UK Ltd

Via GlobeNewswire

Smith+Nephew introduces expanded enterprise ASC Solutions Strategy to support growth, performance and value-based care

July 21, 2026

From Smith & Nephew UK Ltd

Via GlobeNewswire

Smith+Nephew introduces groundbreaking LYNX™ COBLATION™ Laryngeal Wand for ENT surgeons

July 15, 2026

From Smith & Nephew UK Ltd

Via GlobeNewswire

A Fresh FDA Catalyst Is Putting Regenerative Wound Care in Focus

June 09, 2026

From Equity Insider

Via GlobeNewswire

Smith+Nephew announces first clinical cases with the next generation CORI◊XT Handheld Robotics Platform across knee and shoulder arthroplasty

June 08, 2026

From Smith & Nephew UK Ltd

Via GlobeNewswire

Smith+Nephew launch next generation LEAF™ Patient Monitoring System – an innovative pressure injury prevention platform delivering proven clinical impact

June 01, 2026

From Smith & Nephew UK Ltd

Via GlobeNewswire

A Reno Biotech Just Rang the Nasdaq Bell — Here’s Why the Whole Regenerative-Medicine Tape Is Worth Watching

May 22, 2026

From World Street Intelligence

Via GlobeNewswire

Smith+Nephew drives progress in chronic wound care with ALLEVYN™COMPLETE CARE Dressing and RENASYS™ EDGE tNPWT set to launch at EWMA 2026

May 05, 2026

From Smith & Nephew UK Ltd

Via GlobeNewswire

New data for Smith+Nephew’s CARTIHEAL◊ AGILI-C◊ Cartilage Repair Implant demonstrates superior pain relief and functional gains at 5-years

April 21, 2026

From Smith & Nephew UK Ltd

Via GlobeNewswire

Smith+Nephew’s REGENETEN◊ Bioinductive Implant shows post-operative recovery times halved, and high healing rates for partial-thickness rotator cuff tears1,*

April 09, 2026

From Smith & Nephew UK Ltd

Via GlobeNewswire

Smith+Nephew launches next-generation ALLEVYN™ COMPLETE CARE Foam Dressing - designed for high performance in wound management and pressure injury prevention

March 10, 2026

From Smith & Nephew UK Ltd

Via GlobeNewswire

Smith+Nephew to showcase advanced Orthopaedic Handheld Robotics, Reconstruction and Trauma technologies during AAOS 2026

March 03, 2026

From Smith & Nephew UK Ltd

Via GlobeNewswire

Smith+Nephew to feature leading rotator cuff repair portfolio including new Tendon Seam™ Repair System and REGENETEN◊ Bioinductive Implant at AAOS 2026

March 02, 2026

From Smith & Nephew UK Ltd

Via GlobeNewswire

Smith+Nephew signs exclusive US distribution agreement with RMR Ortho for patented technology that provides a unique dynamic compression nitinol fixation option (A'TOMIC™) to our surgeons

February 24, 2026

From Smith & Nephew UK Ltd

Via GlobeNewswire

Smith+Nephew signs distribution agreement with SI-BONE

February 23, 2026

From Smith & Nephew UK Ltd

Via GlobeNewswire

Frequently Asked Questions

Is Smith & Nephew SNATS, Inc. Common Stock publicly traded?

Yes, Smith & Nephew SNATS, Inc. Common Stock is publicly traded.

What exchange does Smith & Nephew SNATS, Inc. Common Stock trade on?

Smith & Nephew SNATS, Inc. Common Stock trades on the New York Stock Exchange

What is the ticker symbol for Smith & Nephew SNATS, Inc. Common Stock?

The ticker symbol for Smith & Nephew SNATS, Inc. Common Stock is SNN on the New York Stock Exchange

What is the current price of Smith & Nephew SNATS, Inc. Common Stock?

The current price of Smith & Nephew SNATS, Inc. Common Stock is 27.42

When was Smith & Nephew SNATS, Inc. Common Stock last traded?

The last trade of Smith & Nephew SNATS, Inc. Common Stock was at 09/11/26 01:23 PM ET

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.